v3.22.0.1

DERIVATIVE FINANCIAL INSTRUMENTS (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of derivative liabilities |
Schedule of derivative liabilities |  |  |  |  |  |
|  | December 31, 2021 |
The financings giving rise to derivative financial instruments |  | Indexed Shares |  |  | Fair Values |
Compound embedded derivatives |  |  | 1,372,797,202 |  |  |  | (2,199,087 | )
Total |  |  | 1,372,797,202 |  |  |  | (2,199,087 | )
The following tables summarize the components of the Company’s derivative liabilities and linked common shares as of December 31, 2020:
|  | December 31, 2020 |
The financings giving rise to derivative financial instruments |  | Indexed Shares |  |  | Fair Values |
Compound embedded derivatives |  |  | 311,625,168 |  |  |  | (739,574 | )
Total |  |  | 311,625,168 |  |  |  | (739,574 | )
The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the three months ended December 31, 2021, and 2020:
The financings giving rise to derivative financial instruments and the income effects: |  | December 31, 2021 |  |  | December 31, 2020 |
Compound embedded derivatives |  | $ | (66,894 | ) |  | $ | 194,410 |
Day one derivative loss |  |  | (45,485 | ) |  |  | (125,408 | )
Total (loss) |  | $ | (112,379 | ) |  | $ | (69,002 | )
The following table summarizes the effects on the Company’s gain (loss) associated with changes in the fair values of the derivative financial instruments by type of financing for the nine months ended December 31, 2021, and 2020:
The financings giving rise to derivative financial instruments and the income effects: |  | December 31, 2021 |  |  | December 31, 2020 |
Compound embedded derivatives |  | $ | (421,836 | ) |  | $ | (592,997 | )
Day one derivative loss |  |  | (45,485 | ) |  |  | (125,408 | )
Total (loss) |  | $ | (467,321 | ) |  | $ | (715,405 | )
Schedule of significant inputs |
Schedule of significant inputs |  |  |  |
|  | December 31, 2021 |
Quoted market price on valuation date |  | $ | 0.0029 |
Contractual conversion rate |  |  | $0.0001-$0.01 |
Contractual term to maturity |  |  | 0.005 Years – 1.0 Years |
Market volatility: |  |  |  |
Equivalent Volatility |  |  | 90.12% - 170.73% |
Interest rate |  |  | 8.00% |
Schedule of changes in fair value of derivatives |
Schedule of changes in fair value of derivatives |  |  |  |  |  |  |  |
|  | December 31, |  |  | March 31, |
|  | 2021 |  |  | 2021 |
Beginning balance |  | $ | 1,137,623 |  |  | $ | 58,790 |
Issuances: |  |  |  |  |  |  |  |
Compound embedded derivatives |  |  | 1,088,514 |  |  |  | 732,416 |
Conversions |  |  | (287,897 | ) |  |  | (859,352 | )
Derivative extinguished / debt repaid in cash |  |  | (160,989 | ) |  |  | (126,892 | )
(Gain) loss on changes in fair value inputs and assumptions reflected in income |  |  | 421,836 |  |  |  | 1,332,661 |
Total |  | $ | 2,199,087 |  |  | $ | 1,137,623 |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of all information related to the key inputs and assumptions (including, at a minimum, but not limited to, and if applicable, quantitative information about discount rates, expected prepayments including the expected weighted-average life of prepayable financial assets, and anticipated credit losses) used in measuring the fair value of assets or liabilities that relate to the transferor's continuing involvement with transferred financial assets, as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719 + Details
Name: | us-gaap_ScheduleOfAssumptionsForFairValueAsOfBalanceSheetDateOfInterestsContinuedToBeHeldByTransferorServicingAssetsOrServicingLiabilitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4E -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative liabilities at fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration